Utilex engages in development and commercialization of immunotherapy for oncology diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: Daeryung Technotown 17 Gasan digital 1-ro 25
City: Geumcheon-gu
State: seoul teugbyeolsi
Zip: 08594
Country: KR
Utilex engages in development and commercialization of immunotherapy for oncology diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Korea Exchange
Ticker Symbol:
263050
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2016 | Series A | 4 | $18.1M |
DS Asset Management G.N. Tech Venture Kolon Investment SNU Bio Angel DS Asset Management G.N. Tech Venture Kolon Investment SNU Bio Angel |
12/2018 | IPO | - | 12/2016 | Series A | $18.9M |
Kolon Investment G.N. Tech Venture |
12/2018 | IPO | - |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|